Studying people who carry a BRCA gene change linked to breast and ovarian cancer
Follows adults carrying a BRCA gene change using questionnaires about their health.
Plain-language title generated from the registry record
Registry title: Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
Key facts
- Where
- Marseille, FranceSee the site
Where in France
- Institut Paoli-CalmettesMarseille, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut Paoli-Calmettes
- Trial code
- NCT03667417
- Record updated
- 14 October 2026
- Original description
Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancersRead full original descriptionShow less
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers
Exclusion: A person of legal age subject to a legal protection measure, or unable to express consent; Impossibility to submit to the follow-up of the test for geographical, social or psychological reasons.
Woman or man, with or without cancer, carrying a deleterious BRCA1/BRCA2 mutation, aged 18 years and over; Woman with or without breast cancer or ovarian cancer at baseline; Man with or without breast cancer at baseline; Signed consent to participation; Affiliation to a social security regimen, or beneficiary of such a regimen.